Cardiovascular Disease

Don’t tolerate cholesterol lowering medications?

We are researching the use of an experimental medication designed to lower the risk of cardiovascular disease in people that don’t respond well to lipid lowering medications.

We are currently recruiting study participants who:

Are 18 to 85 years old
Are intolerant to at least one statin (cholesterol lowering drug), for example, due to increased side-effects
Have a history of, or are at high risk for, cardiovascular disease

Participants will need to attend at least 9 clinic visits over a 2 year period, then one clinic visit every 6 months to a maximum of approximately 4.5 years.

To see if you are eligible, complete the questionnaire below or call the Clinical Trials Centre on 07 5456 3797.

Full title: 1002-043 A randomised, double-blind, placebo-controlled study to assess the effects of Bempedoic Acid (ETC-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant.

Ethics approval – Bellberry Human Research Ethics Committee

If you experience difficulty completing the survey please email trials@usc.edu.au

Start Questionnaire?

Are you between 18 and 85 years old?

Are you statin intolerant? For example, have you had adverse reactions to cholesterol lowering medications that went away after you stopped taking these medications?

If you are female, are you willing to use an acceptable method of birth control throughout the study and for 30 days after the study finishes? Acceptable methods include oral/implantable/intrauterine birth control.

Cardiovascular Disease